SOUNDTRACK-B: A phase 2 single-arm study to evaluate the efficacy and safety of surovatamig (AZD0486) in relapsed or refractory B-cell non-Hodgkin lymphoma
Year: 2025
Type: conference-abstract
Source: Blood
Institutions: The University of Western Australia, Sir Charles Gairdner Hospital, Macquarie University, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, Copenhagen University Hospital, Rigshospitalet, Universitätsklinikum Würzburg, Samsung Medical Center, Sungkyunkwan University, The Cancer Institute Hospital, Japanese Foundation For Cancer Research, AstraZeneca (United States), UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417006182